DR. PHOEBE CONSUE KING M.D.
Prescription History 1760630321
Internal Medicine - Pulmonary Disease in Sandy, UT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PHOEBE CONSUE KING M.D., an active Pulmonary Disease specialist practicing in Sandy, UT. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 423 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisone, which accounts for 76 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other UT PrescribersVs. UT Avg |
|---|---|---|---|
| Prednisone | 76 | $7.73 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 76 Medicare prescriptions for Prednisone, about 2.2 times the volume of the typical Utah prescriber of this medication (35). Medicare paid an average of $7.73 per fill, versus $7.04 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 102 30-Day Fills standardized to 30-day supplies 2,284 Days of Medication total across all patients in 2023 | |||
| Montelukast Sodium | 56 | $18.84 | ▲ More than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. In 2023, this provider wrote 56 Medicare prescriptions for Montelukast Sodium, about 1.4 times the volume of the typical Utah prescriber of this medication (40). Medicare paid an average of $18.84 per fill, versus $18.57 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 135 30-Day Fills standardized to 30-day supplies 4,050 Days of Medication total across all patients in 2023 | |||
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $1,026.94 | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 44 Medicare prescriptions for Trelegy Ellipta, about 1.3 times the volume of the typical Utah prescriber of this medication (33). Medicare paid an average of $1,026.94 per fill, versus $823.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66 30-Day Fills standardized to 30-day supplies 1,980 Days of Medication total across all patients in 2023 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $29.20▼ below UT avg | ≈ Typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 39 Medicare prescriptions for Albuterol Sulfate Hfa, about the same volume as the typical Utah prescriber of this medication (38). Medicare paid an average of $29.20 per fill, versus $52.20 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 42.7 30-Day Fills standardized to 30-day supplies 1,048 Days of Medication total across all patients in 2023 | |||
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $747.15▼ below UT avg | ▲ More than typical |
About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma. In 2023, this provider wrote 39 Medicare prescriptions for Breztri Aerosphere, about 1.5 times the volume of the typical Utah prescriber of this medication (26). Medicare paid an average of $747.15 per fill, versus $773.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 45 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2023 | |||
| Breo ElliptaFluticasone/Vilanterol | 31 | $622.55 | ▲ More than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 31 Medicare prescriptions for Breo Ellipta, about 1.4 times the volume of the typical Utah prescriber of this medication (22). Medicare paid an average of $622.55 per fill, versus $536.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2023 | |||
| Azithromycin | 29 | $19.94 | ≈ Typical |
About Azithromycin: This medication is used to treat certain eye infections. Show more ▾ It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2023, this provider wrote 29 Medicare prescriptions for Azithromycin, about the same volume as the typical Utah prescriber of this medication (29). Medicare paid an average of $19.94 per fill, versus $10.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42.8 30-Day Fills standardized to 30-day supplies 1,251 Days of Medication total across all patients in 2023 | |||
| SymbicortBudesonide/Formoterol Fumarate | 28 | $528.80▼ below UT avg | ≈ Typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 28 Medicare prescriptions for Symbicort, about 1.2 times the volume of the typical Utah prescriber of this medication (24). Medicare paid an average of $528.80 per fill, versus $563.00 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 41 30-Day Fills standardized to 30-day supplies 1,230 Days of Medication total across all patients in 2023 | |||
| OfevNintedanib Esylate | 17 | $13,131.66 | ▼ Less than typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2023, this provider wrote 17 Medicare prescriptions for Ofev, about half the volume of the typical Utah prescriber of this medication (37). Medicare paid an average of $13,131.66 per fill, versus $12,528.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $9.56▼ below UT avg | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate. In 2023, this provider wrote 15 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 71% of the volume of the typical Utah prescriber of this medication (21). Medicare paid an average of $9.56 per fill, versus $16.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 15 30-Day Fills standardized to 30-day supplies 137 Days of Medication total across all patients in 2023 | |||
| Ropinirole Hcl | 13 | $3.60▼ below UT avg | ▼ Less than typical |
About Ropinirole Hcl: This medication is used alone or with other medications to treat Parkinson's disease. Show more ▾ It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move (on-off syndrome). Ropinirole works by helping to restore the balance of a certain natural substance (dopamine) in the brain. In 2023, this provider wrote 13 Medicare prescriptions for Ropinirole Hcl, about half the volume of the typical Utah prescriber of this medication (27). Medicare paid an average of $3.60 per fill, versus $26.61 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $497.99▼ below UT avg | ▼ Less than typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2023, this provider wrote 13 Medicare prescriptions for Stiolto Respimat, about half the volume of the typical Utah prescriber of this medication (24). Medicare paid an average of $497.99 per fill, versus $632.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| NucalaMepolizumab | 12 | $3,438.64▼ below UT avg | ≈ Typical |
About Nucala: This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab is also used to treat certain other immune system disorders (chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome). This medication works by decreasing a certain type of white blood cell (eosinophils). This effect helps reduce swelling (inflammation) of the airways to make breathing easier. It may also help reduce the size of nasal polyps, and lessen symptoms such as runny/stuffy nose, mucus in the throat, loss of smell, facial pain, and tiredness. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 12 Medicare prescriptions for Nucala, about 86% of the volume of the typical Utah prescriber of this medication (14). Medicare paid an average of $3,438.64 per fill, versus $4,778.29 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average UT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the UT average for this medication. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| TezspireTezepelumab-Ekko | 11 | $4,116.66 | – No State Data |
About Tezspire: This medication is used with other medications to control and prevent symptoms of severe asthma (such as wheezing and shortness of breath). Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Tezepelumab belongs to a class of medications known as monoclonal antibodies. It helps reduce swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 11 Medicare prescriptions for Tezspire. Medicare paid an average of $4,116.66 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $4,116.66 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. PHOEBE CONSUE KING M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Sandy, UT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among UT prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
